Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Black Diamond Therapeutics, Inc.

Clinical trials sponsored by Black Diamond Therapeutics, Inc., explained in plain language.

Black Diamond Therapeutics, Inc. BDTX NASDAQ

Clinical-stage oncology company developing precision cancer therapies.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet finished but already full! 1

New pill targets tough cancers: early trial underway

Disease control Ongoing

This study tests an experimental oral drug called silevertinib (BDTX-1535) in about 200 adults with advanced non-small cell lung cancer or glioblastoma, a type of brain cancer. The drug is designed to block specific EGFR mutations that help these cancers grow. The trial has two p…

Phase: PHASE1, PHASE2 • Sponsor: Black Diamond Therapeutics, Inc. • Aim: Disease control

Last updated Jul 24, 2026 00:00 UTC